Sanofi Pasteur has rejected a request from the US Army to set an affordable US price for a Zika virus vaccine that the company is developing with American taxpayer funds, prompting an angry response from Senator Bernie Sanders.
For months, Sanders has pushed the Army to negotiate a more favorable agreement with Sanofi, which is one of the world’s largest vaccine makers and which has already received a $43 million US research grant. But Sanofi recently refused, according to an Army timeline of events reviewed by STAT.
The rejection comes amid negotiations the Army is holding to grant Sanofi a license to make and sell a Zika vaccine. But the prospect of giving Sanofi an exclusive license to sell a potential blockbuster — depending upon how extensively the virus travels — at whatever price it wants, has upset various lawmakers and advocacy groups, who are pressing the Army to insist on affordable pricing.
About the Author Reprints
Take a look at INOVIO vaccine! Forget Sanofi!
They claim that this is the only company willing to take on the patents. Sanofia has spent consuderable sums on their work, changing horse will only slow the process.
They claim that this is the only company willing to take on the patents. Sanofia has spent consuderable sums on their work, changing horse will only slow the process.